Dr. Sklar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Cedar St
Lauder Hall, Room 108
New Haven, CT 06510Phone+1 203-785-3624Fax+1 203-785-7037
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1977 - 1981
Yale School of MedicineClass of 1977
Certifications & Licensure
CT State Medical License 2003 - 2021
Publications & Presentations
PubMed
- 69 citationsT-cell lymphoma and the virus-associated hemophagocytic syndrome.Fiona E. Craig, Clare Cn, Jeffrey Sklar, Peter M. Banks
American Journal of Clinical Pathology. 1992-02-01 - 72 citationsCorrelation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.Deborah Schofield, Daniel C. West, Douglas C. Anthony, R Marshal, Jeffrey Sklar
The American Journal of Pathology. 1995-02-01 - 37 citationsCeralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations).Haider Mahdi, Navid Hafez, Deborah Blythe Doroshow, Davendra Sohal, Vickie L. Keedy
JCO Precision Oncology. 2021-09-07
Press Mentions
Precipio and Transgenomic Announce Experts from Yale and Harvard Joining New Scientific Advisory Board to Support Merged Company’s Growth InitiativesJune 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
